Loading…
HCA Healthcare, Inc. is projected to rise to $445.14 by 2027, a +14% move from its current price of $392.15. HCA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $386.73 | $392.30 | $397.94 | +0.04% |
| May 30 | $384.60 | $392.45 | $400.46 | +0.08% |
| May 31 | $383.00 | $392.60 | $402.43 | +0.11% |
| Jun 1 | $381.68 | $392.75 | $404.13 | +0.15% |
| Jun 2 | $380.54 | $392.90 | $405.65 | +0.19% |
| Jun 3 | $379.53 | $393.05 | $407.05 | +0.23% |
| Jun 4 | $378.61 | $393.19 | $408.34 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $378.61 | $393.19 | $408.34 | +0.27% |
| Week 2 | $373.72 | $394.24 | $415.89 | +0.53% |
| Week 3 | $370.24 | $395.29 | $422.04 | +0.80% |
| Week 4 | $367.48 | $396.35 | $427.47 | +1.07% |
| Week 5 | $365.19 | $397.40 | $432.46 | +1.34% |
| Week 6 | $363.22 | $398.46 | $437.12 | +1.61% |
| Week 7 | $361.50 | $399.52 | $441.55 | +1.88% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HCA Healthcare, Inc. is a healthcare services company that operates in the United States. It owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities.
Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. HCA Healthcare was founded in 1968 and is headquartered in Nashville, Tennessee.
HCA Healthcare, Inc. trades under the symbol HCA and currently has a price of $394.07 per share with a market capitalization of $87.42B. It is ranked 181 in market capitalization.
The near-term outlook shows a neutral stance, with the 2026 forecast average price at $394.07 and a 0% ROI, indicating little expected movement from the current level.
Longer-term forecasts point to a rising trajectory and stronger upside, with substantial returns projected in later years (for example, an avg price of $609.84 in 2030 with a 54.8% ROI, and a forecast pathway that climbs to high levels by 2050). These are estimates and not guarantees.
A major floor 16.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 24.6% above — a clean break opens room to run.
A major ceiling 39.0% above — clearing it would confirm fresh momentum.
Key HCA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HCA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $393.57 | Sell | $396.37 | Sell |
| MA 10 | $407.86 | Sell | $404.92 | Sell |
| MA 20 | $419.33 | Sell | $419.46 | Sell |
| MA 50 | $456.76 | Sell | $448.47 | Sell |
| MA 100 | $481.83 | Sell | $462.68 | Sell |
| MA 200 | $462.43 | Sell | $452.27 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 24.25 | Buy |
| Stoch RSI (14) | 5.22 | Buy |
| CCI (20) | -126.34 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -1.54 | Sell |
| ROC (12) | -9.89 | Sell |
| Bollinger %B (20,2) | 0.08 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.56 | Sell |
| Awesome (5,34) | -49.06 | Sell |
| Ultimate (7,14,28) | 12.63 | Buy |
| Momentum (10) | -37.54 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 385.69 | Buy |
| ADX (14) | 37.59 | Sell |
| ATR (14) | 5.38 | Info |
The 30-day technical picture is neutral, with RSI14 at 20. The SMA50 is $462.23 and the SMA200 is $462.29, framing a price that currently sits near the $392.56 support and $498.66 resistance levels.
Over the last 30 days, the price has traded within a range of $356.60 to $435.48, showing limited near-term movement within this band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $392.15 | $392.15 | $511.78 | 0% | Neutral | |
| $363.65 | $445.14 | $570.36 | +14% | Neutral | |
| $391.49 | $487.96 | $641.56 | +24% | Bullish | |
| $403.69 | $510.80 | $685.56 | +30% | Bullish | |
| $470.12 | $602.77 | $823.32 | +54% | Bullish | |
| $535.83 | $695.32 | $964.53 | +77% | Bullish | |
| $557.29 | $731.27 | $1,028.65 | +86% | Bullish | |
| $600.49 | $796.19 | $1,134.33 | +103% | Bullish | |
| $592.84 | $793.82 | $1,144.34 | +102% | Bullish | |
| $606.75 | $820.09 | $1,195.26 | +109% | Bullish | |
| $876.28 | $1,235.11 | $1,885.90 | +215% | Bullish | |
| $1,653.96 | $2,499.82 | $4,090.38 | +537% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $392.15 | $392.15 | $460.37 | +0.00% |
| June 2026 | $347.41 | $405.28 | $481.95 | +3.35% |
| July 2026 | $346.02 | $405.98 | $487.35 | +0.17% |
| August 2026 | $343.26 | $404.55 | $489.17 | -0.35% |
| September 2026 | $349.81 | $413.81 | $503.34 | +2.29% |
| October 2026 | $352.98 | $418.98 | $512.37 | +1.25% |
| November 2026 | $346.70 | $412.76 | $507.15 | -1.48% |
| December 2026 | $347.32 | $414.68 | $511.78 | +0.47% |
Click any year to see its month-by-month HCA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, HCA could reach as high as $511.78, with a base case around $392.15 and support toward $392.15 — roughly 0% from $392.15. A consolidation phase looks the most probable path here.
Expect HCA to range from $363.65 to $570.36 through 2027. The $445.14 average target implies a +14% move from current prices. That is up +14% on the projected 2026 average. Price action looks broadly range-bound.
The HCA price prediction for 2028 points to an average of $487.96 (low $391.49, high $641.56) — a potential gain of +24% on today's $392.15. Buyers look set to stay in control over this stretch.
In 2029, HCA is projected to trade between $403.69 and $685.56, averaging $510.80 — a potential gain of +30% from today's $392.15. That is up +5% on the projected 2028 average. Momentum favours further upside here.
HCA Healthcare, Inc.'s 2030 outlook centres on $602.77, within a $470.12 to $823.32 range. That is up +18% on the projected 2029 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, HCA could reach as high as $964.53, with a base case around $695.32 and support toward $535.83 — roughly +77% from $392.15. Momentum favours further upside here.
Expect HCA to range from $557.29 to $1,028.65 through 2032. The $731.27 average target implies a +86% move from current prices. That is up +5% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The HCA price prediction for 2033 points to an average of $796.19 (low $600.49, high $1,134.33) — a potential gain of +103% on today's $392.15. Momentum favours further upside here.
In 2034, HCA is projected to trade between $592.84 and $1,144.34, averaging $793.82 — a potential gain of +102% from today's $392.15. That is 0% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
HCA Healthcare, Inc.'s 2035 outlook centres on $820.09, within a $606.75 to $1,195.26 range. That is up +3% on the projected 2034 average. That marks a +109% change versus current levels. Momentum favours further upside here.
By 2040, HCA could reach as high as $1,885.90, with a base case around $1,235.11 and support toward $876.28 — roughly +215% from $392.15. Buyers look set to stay in control over this stretch.
Expect HCA to range from $1,653.96 to $4,090.38 through 2050. The $2,499.82 average target implies a +537% move from current prices. That is up +102% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HCA today (≈ 2.550045 HCA) could be worth
$6,374.65
+$5,374.65 (+537%) by 2050 · US Dollar
Based on the average projected HCA price of $2,499.82 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HCAwould be worth at today's price.
$1,000 invested in HCA on May 27, 2025 (≈ 2.639846 HCA) would be worth
$1,035.22
+$35.22 (+3.5%) today · 1.04× · US Dollar
Based on a HCA entry price of $378.81 vs. today's $392.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $396.67 | $988.61 | -1.1% |
| 1 month ago | $445.77 | $879.71 | -12.0% |
| 3 months ago | $525.88 | $745.7 | -25.4% |
| 6 months ago | $508.29 | $771.51 | -22.8% |
| 1 year ago | $378.81 | $1,035.22 | +3.5% |
| All time (5.0y) ago | $215.87 | $1,816.6 | +81.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HCA forecast.
Our base-case forecast reaches $780.00 around 2033.
Implied market cap at $780.00: $173.04B
Across the multi-year forecast, the path is broadly bullish after 2026. In 2027 the average price is projected at $448.97 with a 13.9% ROI and NEUTRAL sentiment. The year 2028 carries an average of $490.87 with a 24.6% ROI and a BULLISH stance, followed by 2029 at $518.01 average and 31.4% ROI.
In 2030 the average price is forecast at $609.84 with a 54.8% ROI and BULLISH sentiment, continuing higher to 2031 with $702.90 average and 78.4% ROI, 2032 at $743.09 average and 88.6% ROI, 2033 at $804.67 average and 104.2% ROI, 2034 at $802.08 average and 103.5% ROI, and 2035 at $835.55 average and 112% ROI, all with BULLISH sentiment.
The forecast extends to 2040 with an average of $1,251.51 and a 217.6% ROI, and to 2050 with an average of $2,556.12 and a 548.6% ROI, maintaining a BULLISH outlook. These figures imply a rising price pathway with higher potential upside over time, but they remain estimates and are not guarantees.
Tap a question to reveal the answer.
The 2030 forecast lists an average price of $609.84 with a 54.8% ROI and a BULLISH sentiment.
Forecasts show a rising average price and positive ROI in multiple years, including 54.8% in 2030, 217.6% by 2040, and 548.6% by 2050, with overall bullish sentiment in later years.
Yes. The forecast maximums exceed $1,000 in several years, including $1,045.46 in 2032 and $1,146.60 in 2033.
Current price is $394.07 per share and market capitalization is $87.42B.
RSI14 is 20 with NEUTRAL sentiment. SMA50 is $462.23 and SMA200 is $462.29, with support at $392.56 and resistance at $498.66. The 30-day price range is $356.60 to $435.48.
HCA Healthcare, Inc. Community Discussion
0Share your HCA Healthcare, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.